Literature DB >> 18982162

Nuanced roles of cytokines in three major human brain disorders.

Lawrence Steinman1.   

Abstract

The three most prevalent human disorders of the CNS in which immunity and inflammation are likely to have vital roles (excluding infection of the CNS) are fever, multiple sclerosis (MS), and Alzheimer disease (AD). As reviewed here, cytokines are critical in the induction of fever, the pathogenesis of MS, and the pathobiology of AD. Indeed, antibodies targeting cytokines have been used as a therapy for individuals with unusual and persistent febrile reactions not responsive to common antipyretics, while a recombinant cytokine is the most popular treatment for the relapsing-remitting form of MS. Although cytokine-modulating therapies are not currently in clinical use for the treatment of AD, cytokines can ameliorate disease pathology in certain experimental models of AD, suggesting a potential for future therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982162      PMCID: PMC2575716          DOI: 10.1172/JCI36532

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Authors:  Marc Feldmann; Ravinder N Maini
Journal:  Nat Med       Date:  2003-10       Impact factor: 53.440

2.  [The role of hemostasis system in the pathogenesis and course of multiple sclerosis].

Authors:  V F Kirichuk; A G Streknev
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2003

Review 3.  Elaborate interactions between the immune and nervous systems.

Authors:  Lawrence Steinman
Journal:  Nat Immunol       Date:  2004-06       Impact factor: 25.606

4.  TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

Authors:  T Wyss-Coray; C Lin; F Yan; G Q Yu; M Rohde; L McConlogue; E Masliah; L Mucke
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

5.  The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.

Authors:  D Chabas; S E Baranzini; D Mitchell; C C Bernard; S R Rittling; D T Denhardt; R A Sobel; C Lock; M Karpuj; R Pedotti; R Heller; J R Oksenberg; L Steinman
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

6.  Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha.

Authors:  Z Ma; H Qin; E N Benveniste
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

7.  Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.

Authors:  M H J Vogt; S Floris; J Killestein; D L Knol; M Smits; F Barkhof; C H Polman; L Nagelkerken
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

Review 8.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

Review 9.  Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed.

Authors:  Charles A Dinarello
Journal:  J Endotoxin Res       Date:  2004

Review 10.  Molecular basis of fever in humans.

Authors:  C A Dinarello; S M Wolff
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

View more
  40 in total

1.  NF-κB in Aging and Disease.

Authors:  Jeremy S Tilstra; Cheryl L Clauson; Laura J Niedernhofer; Paul D Robbins
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Modulation of postoperative cognitive decline via blockade of inflammatory cytokines outside the brain.

Authors:  Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

3.  LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14.

Authors:  Leonid Tarassishin; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2014-03-21       Impact factor: 7.452

Review 4.  No quiet surrender: molecular guardians in multiple sclerosis brain.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2015-04-01       Impact factor: 14.808

Review 5.  A molecular trio in relapse and remission in multiple sclerosis.

Authors:  Lawrence Steinman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

Review 6.  Many cytokines are very useful therapeutic targets in disease.

Authors:  Marc Feldmann
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

7.  Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

Authors:  Markus Britschgi; Kaspar Rufibach; Sarah L Bauer Huang; Christopher M Clark; Jeffrey A Kaye; Ge Li; Elaine R Peskind; Joseph F Quinn; Douglas R Galasko; Tony Wyss-Coray
Journal:  Mol Cell Proteomics       Date:  2011-07-08       Impact factor: 5.911

Review 8.  Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.

Authors:  M J Hofer; I L Campbell
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

Review 9.  Transgenic models for cytokine-induced neurological disease.

Authors:  Iain L Campbell; Markus J Hofer; Axel Pagenstecher
Journal:  Biochim Biophys Acta       Date:  2009-10-14

10.  Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males.

Authors:  Yi-Chyan Chen; Wei-Win Lin; Yu-Jung Chen; Wei-Chung Mao; Yi-Jen Hung
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.